Who owns RESHAPE LIFESCIENCES INC?
- Ticker: RSLS
- CUSIP Number: 76090r200
Tip: Access positions for across all investors
Analyze quarterly positions in Reshape Lifesciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Reshape Lifesciences stock
Who bought or sold RESHAPE LIFESCIENCES INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Two Sigma Securities | 76k | $19k | 448% | Dec 2023 |
|
Virtu Financial | 74k | $18k | 295% | Dec 2023 |
|
Citadel Advisors | 73k | $18k | 100% | Dec 2023 |
|
Vanguard Group | 50k | $13k | 0% | Dec 2023 |
|
Millennium Management | 21k | $5.3k | 100% | Dec 2023 |
|
Wells Fargo & Company | 101.00 | $24.997500 | 321% | Dec 2023 |
|
Advisor Group Holdings | 5.00 | $1.000000 | -50% | Dec 2023 |
|
UBS Group | 2.00 | $1.000000 | -100% | Dec 2023 |
|
Who sold out of Reshape Lifesciences?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Cornerstone Planning Group | Sep 2023 | 135.00 | $45.994500 |
Bank of America Corporation | Sep 2023 | 100.00 | $34.000000 |